Related Experiment Videos
Antifungal therapy for keratomycoses
Nihal Ganegoda1, Srinivas K Rao
1Medical Research Foundation, Nadu, India.
Expert Opinion on Pharmacotherapy
|April 23, 2004
Summary
Fungal keratitis (fungal eye infections) treatment is improving with new drugs and delivery methods. Early diagnosis and molecular techniques are key for managing these serious corneal infections.
Area of Science:
- Ophthalmology
- Mycology
- Infectious Diseases
Background:
- Keratomycoses (fungal eye infections) are a growing cause of ocular morbidity, particularly in developing nations.
- Current antifungal treatments face challenges including poor corneal penetration, fungistatic action, drug resistance, and inadequate sensitivity testing.
- Limited understanding of synergistic and antagonistic interactions between antifungal agents hinders optimal combination therapy.
Purpose of the Study:
- To summarize recent advancements in the management of fungal keratitis over the past two years.
- To provide updated guidelines for treating serious corneal infections caused by fungi.
- To highlight the importance of early diagnosis and emerging molecular techniques.
Main Methods:
- Review of recent scientific literature (past 2 years) on fungal keratitis treatment.
- Analysis of new drug formulations, novel antifungal agents, and innovative drug delivery systems.
- Discussion of diagnostic advancements, including molecular biological techniques.
Main Results:
- Encouraging outcomes reported in recent studies for fungal keratitis treatment.
- Development of improved drug formulations and new antifungal agents.
- Advancements in drug delivery methods for ocular infections.
Conclusions:
- Despite challenges, progress in antifungal therapies and drug delivery offers hope for treating fungal keratitis.
- Early diagnosis and the potential of molecular techniques are crucial for future management.
- Updated guidelines are essential for effectively managing these severe corneal infections.